ArticleImmunity, inflammation and disease2024

Immunogenicity of two-dose sinopharm BBIB-CorV vaccine in Morocco: One-year follow-up and neutralizing activity against severe acute respiratory syndrome coronavirus 2 variants of concern.

Maha Ouarab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.